Cosmetic
Platelet-rich plasma and fibrin use growth factors from your own blood to improve skin quality, reduce dark circles, and enhance periocular treatments.
Medically reviewed by Morris E. Hartstein, MD, FACSOculoplastic SurgeonLast updated June 2026
Part of our complete guide to Periocular Rejuvenation — this page covers PRP periocular therapy in depth.
Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) are autologous biologic therapies that harness concentrated growth factors from a patient’s own blood to stimulate tissue repair, improve skin quality, and rejuvenate the delicate periocular region. Originally developed for orthopedic and dental applications, these treatments have become increasingly popular for cosmetic facial rejuvenation — particularly for under-eye dark circles, fine lines, and crepey skin where traditional fillers may be poorly suited. For oculoplastic surgeons, PRP and PRF represent a valuable addition to the periocular toolkit, but one that demands the same anatomical respect and clinical judgment as any injectable in this unforgiving region.
Unlike synthetic fillers or neuromodulators, PRP and PRF do not add volume or paralyze muscle. Instead, they recruit the body’s own regenerative machinery — signaling fibroblasts to produce new collagen, encouraging angiogenesis, and modulating inflammation. The result is a gradual improvement in skin quality, tone, and texture rather than a dramatic structural change. Understanding what these therapies can and cannot deliver is essential to setting realistic expectations and choosing the right treatment.
Although the names sound similar, PRP and PRF are produced differently and behave differently in tissue. Both begin with a small venous blood draw — typically 10 to 30 mL — that is processed in a centrifuge to separate platelets and plasma from red blood cells. The key differences lie in how that separation is performed.
PRP (platelet-rich plasma) is considered the first generation of platelet concentrates. Blood is collected into tubes containing an anticoagulant (typically sodium citrate) and spun at relatively high speeds. The resulting product is a liquid plasma fraction enriched with platelets, usually 3 to 5 times baseline concentration. Because PRP remains liquid, it injects smoothly and can be activated with calcium chloride to trigger immediate growth factor release.
PRF (platelet-rich fibrin) is the second-generation evolution. PRF uses no anticoagulant and a slower, gentler centrifugation. Without anticoagulant, the natural clotting cascade begins, producing a fibrin matrix that traps platelets, leukocytes, and growth factors. The resulting product is a thicker, gel-like substance that releases growth factors slowly over 7 to 14 days, compared with the rapid burst from PRP. Newer protocols also produce liquid PRF (sometimes called i-PRF or injectable PRF), which combines easier injection with slower growth factor release.
Most oculoplastic surgeons now prefer PRF or liquid PRF for periocular work because the sustained growth factor release more closely matches the slow timeline of collagen remodeling, and the absence of additives means a truly autologous product.
Platelets are best known for their role in clotting, but they also carry hundreds of bioactive proteins inside their alpha granules. When platelets are concentrated and delivered to tissue, they release a cocktail of growth factors that orchestrate wound healing and tissue regeneration. The most clinically relevant include:
In the periocular skin, this growth factor signaling translates to thicker dermis, improved elasticity, better microcirculation, and a modest reduction in pigmentation. The effect is gradual — collagen remodeling unfolds over 8 to 12 weeks — and cumulative with repeated treatments. Unlike a filler that disappears when hyaluronidase is injected, PRP and PRF effects are biologically integrated and may persist for several months, though durability varies between patients and maintenance treatments are usually needed.
PRP and PRF are biologic regenerative therapies, not volumizing fillers. For true hollowing in the tear trough, hyaluronic acid fillers or facial fat grafting remain more appropriate.
The periocular region presents unique challenges for cosmetic treatment. Skin here is thinner than anywhere else on the body, lies directly over delicate orbital structures, and shows aging early. Hyaluronic acid fillers can correct volume loss but sometimes produce a bluish discoloration (the Tyndall effect) or chronic swelling. Lasers improve texture but require downtime. PRP and PRF fill an intermediate niche — gentle, regenerative, and well-suited to the periocular environment.
Dark circles have multiple causes: thin skin revealing underlying vasculature, pigmentation, shadowing from volume loss, and venous congestion. PRP and PRF are particularly well-suited to the vascular component — growth factor stimulation thickens the overlying dermis, improves microcirculation, and reduces the visibility of underlying veins. Some pigmentary improvement may also occur through modulation of melanocyte activity, though this is less predictable.
Crepey, thin periocular skin responds well to PRP and PRF because growth factor stimulation rebuilds dermal collagen. Patients often report that makeup applies more smoothly and that their skin looks “rested” rather than dramatically different. This is a quality-of-skin improvement, not a wrinkle eraser.
One of the most powerful applications is using PRP or PRF to enhance other procedures — mixed with fat during facial fat grafting to potentially improve graft survival, applied topically after RF microneedling to accelerate healing, or following laser resurfacing to reduce downtime.
A typical periocular PRP or PRF session takes about an hour from arrival to discharge. The process is straightforward but every step matters for the quality of the final product.
Injection technique in the periocular region must be exquisitely superficial — intradermal or immediately subdermal — to avoid the rich vascular network around the orbit. Deep injection serves no purpose for skin rejuvenation and dramatically raises the risk of bruising or, in rare cases, vascular complications.
Important: Although PRP and PRF are autologous, periocular injections can still cause bruising, swelling, lumps, infection, and (rarely) vascular occlusion, which can in extreme cases lead to skin necrosis or permanent vision loss. The supratrochlear and supraorbital vessels lie within injection territory and demand respect.
Honesty about the evidence base is essential. Compared with the decades of randomized trial data supporting blepharoplasty or even hyaluronic acid fillers, the literature on periocular PRP and PRF is younger, smaller, and more heterogeneous. Most published studies are case series or small comparative trials, and outcome measures vary widely.
That said, the trajectory of the evidence is encouraging. Multiple studies have demonstrated measurable improvements in periorbital dark circles, skin elasticity, and patient satisfaction following PRP treatment. Histologic studies show increased collagen and elastin in treated skin. The biologic plausibility — growth factor signaling driving fibroblast activity — is well established.
What PRP and PRF cannot do:
Patients hoping for a surgical-grade result from a biologic injection will be disappointed. The honest conversation is about gradual, modest improvement in skin quality — valuable, but bounded.
PRP and PRF results are cumulative. A single session can produce visible improvement, but most patients achieve their best outcome with a series of treatments spaced 4 to 6 weeks apart.
| Goal | Typical Series | Maintenance |
|---|---|---|
| Under-eye dark circles | 3–4 sessions, 4–6 weeks apart | Every 6–12 months |
| Skin quality / fine lines | 3 sessions, 6 weeks apart | Yearly |
| Adjunct to microneedling | 3–4 combined sessions | Yearly |
| Adjunct to fat grafting | Single intraoperative use | N/A |
Results typically become visible 4 to 8 weeks after the first session and continue to improve as the series progresses. Maintenance treatments help preserve gains, as ongoing aging, sun exposure, and gravity continue their work regardless.
Some of the most effective uses of PRP and PRF are in combination with other periocular procedures, where their regenerative signaling amplifies the results of the primary treatment.
This is perhaps the most popular combination. RF microneedling creates controlled microchannels and delivers thermal energy to stimulate collagen. Topical PRP applied during the procedure soaks into those channels, delivering growth factors directly to the dermis. Patients often report faster recovery and enhanced skin quality compared with microneedling alone.
When mixed with harvested fat before injection, PRP may improve adipocyte survival and integration. While not all studies show benefit, the rationale — growth factor support during the vulnerable early days after grafting — is sound, and many surgeons routinely incorporate PRP into their facial fat grafting protocols.
Following ablative or fractional laser treatment, topical PRP can accelerate re-epithelialization and reduce post-procedure redness. This is especially valuable around the eyes where downtime visibility is a concern.
PRP and botulinum toxin work on different targets — skin quality versus muscle activity — and combine well in a comprehensive skin rejuvenation plan.
Thoughtful combination — not piling on every modality — produces the best periocular outcomes. A surgical consultation can help map a sequenced plan tailored to your anatomy and goals.
PRP and PRF are increasingly offered in medspas, dermatology offices, and even by non-physician injectors. The procedure itself — draw blood, spin, inject — appears simple. But the periocular region is one of the most anatomically complex areas of the face, and complications here have unique consequences.
An ASOPRS fellowship-trained oculoplastic surgeon brings a perspective that other providers cannot match:
The most common mistake in periocular cosmetic medicine is treating an anatomical problem with the wrong tool. A patient with significant lower eyelid fat herniation will not be helped by PRP, no matter how many sessions are performed. A patient with true brow ptosis needs a brow lift, not skin treatments. Knowing when to say “PRP isn’t the right answer for you” is as important as knowing how to perform the injection.
PRP and PRF are valuable, evidence-supported additions to the cosmetic periocular toolkit when used in the right patients for the right indications. They will not replace surgery, but they offer a regenerative option for skin quality and dark circles that fits comfortably alongside other modalities. If you are considering PRP or PRF for your eyes, work with a surgeon who understands the full spectrum of periocular care. Find an ASOPRS-trained oculoplastic surgeon in your area to discuss whether PRP, PRF, or another approach best matches your anatomy and goals.
Schedule a consultation with Morris E. Hartstein, MD, FACS to learn if this procedure is right for you.
